Evidence map›Paper›PMID 26993771›Full record

ArticleOncotarget2016

Immortalization capacity of HPV types is inversely related to chromosomal instability.

Denise M Schütze, Oscar Krijgsman, Peter J F Snijders, Bauke Ylstra, Joachim Weischenfeldt, Balca R Mardin, Adrian M Stütz, Jan O Korbel, Johan P de Winter, Chris J L M Meijer and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Chromothripsis in cancer.Nature reviews. Cancer · 2025
    Review
  3. Article
  4. Chromothripsis.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Molecular events leading to HPV-induced high grade neoplasia.Papillomavirus research (Amsterdam, Netherlands) · 2016
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Denise M SchützeDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Oscar KrijgsmanDepartment of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Peter J F SnijdersDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Bauke YlstraDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Joachim WeischenfeldtGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Balca R MardinGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Adrian M StützGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Jan O KorbelGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Johan P de WinterDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Chris J L M MeijerDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Wim G V QuintDDL Diagnostic Laboratory, Voorburg, The Netherlands.
Leontien BoschDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Saskia M WiltingDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Renske D M SteenbergenDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Amsterdam UMC Location VUmc · NLEuropean Molecular Biology Laboratory · DEDDL Diagnostic Laboratory · NLThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-risk human papillomavirus (hrHPV) types induce immortalization of primary human epithelial cells. Previously we demonstrated that immortalization of human foreskin keratinocytes (HFKs) is HPV type dependent, as reflected by the presence or absence of a crisis period before reaching immortality. This study determined how the immortalization capacity of ten hrHPV types relates to DNA damage induction and overall genomic instability in HFKs.Twenty five cell cultures obtained by transduction of ten hrHPV types (i.e. HPV16/18/31/33/35/45/51/59/66/70 E6E7) in two or three HFK donors each were studied.All hrHPV-transduced HFKs showed an increased number of double strand DNA breaks compared to controls, without exhibiting significant differences between types. However, immortal descendants of HPV-transduced HFKs that underwent a prior crisis period (HPV45/51/59/66/70-transduced HFKs) showed significantly more chromosomal aberrations compared to those without crisis (HPV16/18/31/33/35-transduced HFKs). Notably, the hTERT locus at 5p was exclusively gained in cells with a history of crisis and coincided with increased expression. Chromothripsis was detected in one cell line in which multiple rearrangements within chromosome 8 resulted in a gain of MYC.Together we demonstrated that upon HPV-induced immortalization, the number of chromosomal aberrations is inversely related to the viral immortalization capacity. We propose that hrHPV types with reduced immortalization capacity in vitro, reflected by a crisis period, require more genetic host cell aberrations to facilitate immortalization than types that can immortalize without crisis. This may in part explain the observed differences in HPV-type prevalence in cervical cancers and emphasizes that changes in the host cell genome contribute to HPV-induced carcinogenesis.

Indexed as

Chromosomal InstabilityHuman papillomavirus 16Human papillomavirus 18HumansPapillomavirus InfectionsarrayCGHchromothripsisE6/E7high-risk HPVtransformation

Identifiers

PMID26993771
PMCPMC5122336
OpenAlexW2325880473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.